Review article · 2023 · Open access
Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation
Cureus, 15(6), e41120 · Published 28 June 2023 · DOI 10.7759/cureus.41120
In brief
“Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation” is a 2023 review article by Muhammad Ali Muzammil and 10 co-authors, published in Cureus. OpenAlex counts 122 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Cureus.
- Citations
- 122
- Most cited in
- 2025 (60)
- Field-weighted impact
- 4.00
- References
- 72
- Authors
- 11
Abstract
Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic, immune-mediated disorder that impacts the gastrointestinal tract. Significant advancements in the diagnosis and treatment of IBD have been made during the past few decades, improving patient outcomes. This narrative review aims to provide an overview of recent developments in the diagnosis and treatment of IBD. Both from an evaluative and therapeutic standpoint, the management of IBD has undergone significant change. The standard of treatment for treating UC and CD patients has changed due to several medical developments. These developments include amino-salicylates, immunosuppressants, biological agents, and new therapeutics. The review also addresses the difficulties in applying these developments in clinical practice. Globally, the prevalence of IBD is rising, with Asia among the regions with the highest rates. These environments provide particular difficulties, such as poor disease knowledge, a lack of diagnostic services, and infectious IBD mimics. These issues must be resolved to diagnose and manage IBD in these populations accurately. New imaging modalities and other improvements in diagnostic methods have increased the precision and early identification of IBD. To reduce problems and improve patient outcomes, healthcare professionals treating patients with IBD must work effectively as a team. An extensive summary of current developments in the diagnosis and treatment of IBD is given in this narrative review. It draws attention to the therapeutic possibilities, difficulties, and uncertainties of integrating these developments into clinical practice. By keeping up with these changes, healthcare practitioners can better care for patients with IBD and improve their quality of life.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Muzammil, M. A., Fariha, F., Patel, T., Sohail, R., Kumar, M., Khan, E. A., Khanam, B., Kumar, S., Khatri, M., Varrassi, G., & Vanga, P. (2023). Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation. Cureus, 15(6), e41120. https://doi.org/10.7759/cureus.41120
MLA 9
Muzammil, Muhammad Ali, et al. “Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation.” Cureus, vol. 15, no. 6, 2023, p. e41120. https://doi.org/10.7759/cureus.41120.
Chicago
Muzammil, Muhammad Ali, Fnu Fariha, Tirath Patel, Rohab Sohail, Munesh Kumar, Ejaz Ahmad Khan, Bushra Khanam, et al. 2023. “Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation.” Cureus 15 (6): e41120. https://doi.org/10.7759/cureus.41120.
Harvard
Muzammil, M. A. et al. (2023) ‘Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation’, Cureus, 15(6), p. e41120. doi:10.7759/cureus.41120.
IEEE
M. A. Muzammil et al., “Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation,” Cureus, vol. 15, no. 6, p. e41120, 2023, doi: 10.7759/cureus.41120.
BibTeX
@article{muzammil2023advancements,
title = {{Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation}},
author = {Muzammil, Muhammad Ali and Fariha, Fnu and Patel, Tirath and Sohail, Rohab and Kumar, Munesh and Khan, Ejaz Ahmad and Khanam, Bushra and Kumar, Satesh and Khatri, Mahima and Varrassi, Giustino and Vanga, Prasanthi},
journal = {Cureus},
year = {2023},
volume = {15},
number = {6},
pages = {e41120},
doi = {10.7759/cureus.41120},
url = {https://doi.org/10.7759/cureus.41120}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 22 | |
| 2025 | 60 | |
| 2026 | 39 |
Its field-weighted citation impact is 4.00: it has been cited 4.00 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- inflammatory bowel disease
- ulcerative colitis
- Crohn's disease
- IBD diagnosis
- IBD treatment
- aminosalicylates
- immunosuppressants
- biological agents
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Muzammil, M. A., Fariha, F., Patel, T., Sohail, R., Kumar, M., Khan, E. A., Khanam, B., Kumar, S., Khatri, M., Varrassi, G., & Vanga, P. (2023). Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation. Cureus, 15(6), e41120. https://doi.org/10.7759/cureus.41120
How many times has this paper been cited?
122 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cureus: sign in and open the PDF from this page.
Who wrote this paper?
Muhammad Ali Muzammil, Fnu Fariha, Tirath Patel, Rohab Sohail, Munesh Kumar, Ejaz Ahmad Khan, Bushra Khanam, Satesh Kumar, Mahima Khatri, Giustino Varrassi, Prasanthi Vanga.
What is the DOI of this paper?
10.7759/cureus.41120, permanently at https://doi.org/10.7759/cureus.41120. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.